Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,169 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Chair Clayton And Division Director Hinman Issue Public Statement On The Importance Of Disclosure In The Current COVID-19 Environment

    On April 8, 2020, the Chair of the U.S. Securities and Exchange Commission (the "SEC") – Jay Clayton – and the Director of the SEC's Division of Corporation Finance – William Hinman – issued a joint statement titled...
    United StatesCoronavirus (COVID-19)
    Mayer Brown
    Mayer Brown
  • Article

    COVID-19 Clinical Trial Data Qualifies For CMS Quality Payment Program

    In an effort to promote the reporting of clinical trial data and amplify the search for COVID-19 therapies, the Centers for Medicare & Medicaid Services (CMS)
    United StatesCoronavirus (COVID-19)
Shipman & Goodwin LLP
Shipman & Goodwin LLP
  • Article

    COVID-19: FDA Clears Path For Test To Screen Asymptomatic Individuals

    The difficulties in accessing laboratory testing and securing prompt results present continuing challenges in the fight to control COVID-19.
    United StatesCoronavirus (COVID-19)
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    FDA And NIH Release Guidance On Ongoing Clinical Trials Affected By COVID-19

    The COVID-19 pandemic has had a major impact on the conduct of clinical trials worldwide. Restrictions on travel, dislocation of clinical trial subjects, and the need of many health care facilities
    United StatesCoronavirus (COVID-19)
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    Frequently Asked Questions: CARES Act Phase 3 Provider Relief Fund General Distribution

    On October, 1, 2020, the U.S. Department of Health and Human Services (HHS) announced the availability of an additional $20 billion in relief funding for providers ...
    United StatesCoronavirus (COVID-19)
    Foley Hoag LLP
    Foley Hoag LLP
  • Article

    Medicaid Under The Biden Administration: The American Rescue Plan Act

    As we previously reported, President Biden recently signed into law a $1.9 trillion dollar stimulus bill, the American Rescue Plan Act (ARPA).
    United StatesCoronavirus (COVID-19)
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Article

    New SBA Guidance On PPP Loans And The Necessity Certification: Safe Harbor For Loans Under $2 Million And SBA Remedies For Certain Adverse Determinations

    Against a backdrop of considerable anxiety in the business community regarding many aspects of the Paycheck Protection Program ("PPP"), the U.S. Small Business Administration ("SBA") today issued its promised guidance.
    United StatesCoronavirus (COVID-19)
    Stites & Harbison PLLC
    Stites & Harbison PLLC
  • Article

    Paycheck Protection Program Flexibility Act

    On June 5, 2020, the Paycheck Protection Program (PPP) Flexibility Act (H.R. 7010) was enacted. The law gives employers more time and flexibility to use their PPP loans while still receiving loan...
    United StatesCoronavirus (COVID-19)
    Arnold & Porter
    Arnold & Porter
  • Article

    Providers May Contact Recovered COVID-19 Patients About Blood And Plasma Donation, According To OCR Guidance

    OCR took care to note that the HIPAA Privacy Rule does not allow providers to engage in marketing communications related to blood and plasma donations without the patient's authorization.
    United StatesCoronavirus (COVID-19)
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Article

    SBA Replaces ‘EZ' With ‘S' To Streamline PPP Loan Forgiveness Application For Many Borrowers

    Therefore, the SBA is prioritizing application efficiency for these borrowers on the assumption that the at-risk dollar amounts are di minimis.
    United StatesCoronavirus (COVID-19)
    Ballard Spahr LLP
    Ballard Spahr LLP
  • Article

    SEC Announces Reporting Relief And Issues Guidance Regarding Disclosures In Light Of COVID-19

    On March 25, 2020, the Securities and Exchange Commission announced that it is extending the filing periods covered by its previously..
    United StatesCoronavirus (COVID-19)
    Duane Morris LLP
    Duane Morris LLP
  • Article

    Staff Guidance On 10-K Part III Information

    The Staff of the Securities and Exchange Commission released additional guidance in the form of a Compliance & Disclosure Interpretation.
    United StatesCoronavirus (COVID-19)
    Mayer Brown
    Mayer Brown
  • Article

    Staff Guidance On Perquisites In A Pandemic

    The Staff of the Securities and Exchange Commission Division of Corporation Finance provided guidance regarding evaluation of whether a benefit provided to a company's executive officer is a perquisite or a personal benefit.
    United StatesCoronavirus (COVID-19)
    Mayer Brown
    Mayer Brown
  • Article

    The CDC's Stances On Fully-Vaccinated Individuals: Details On The Revised Guidance

    On March 8, 2021, the U.S. Centers for Disease Control and Prevention issued new interim recommendations regarding individuals who have been fully vaccinated against COVID-19.
    United StatesCoronavirus (COVID-19)
    Ogletree, Deakins, Nash, Smoak & Stewart
    Ogletree, Deakins, Nash, Smoak & Stewart
  • Article

    A Message From Groom On COVID-19

    As concerns over COVID-19 in the U.S. have escalated and additional steps to combat it have been announced by federal, state and local authorities, Groom remains committed to delivering
    United StatesCorporate/Commercial Law
    Groom Law Group, Chartered
    Groom Law Group, Chartered
  • Article

    SEC Provides Relief To Investment Advisers From Form ADV And Form PF Obligations Due To Coronavirus

    On March 13, the Securities and Exchange Commission (the "SEC") announced regulatory relief for investment advisers whose operations may be affected by the coronavirus (the "Order").
    United StatesCorporate/Commercial Law
    Cleary Gottlieb Steen & Hamilton LLP
    Cleary Gottlieb Steen & Hamilton LLP
  • Article

    Parenting Plans During A Pandemic: 5 Tips For Complying With Parenting Orders

    One of the most common question family law attorneys have been receiving is whether parents who live separate and apart must still comply with parenting orders during the pandemic.
    United StatesFamily and Matrimonial
    Dickinson Wright PLLC
    Dickinson Wright PLLC
  • Article

    FDA Approves Veklury (Remdesivir) As The First Treatment For COVID-19

    On October 22, 2020, the U.S. Food and Drug Administration (FDA) formally approved Veklury (remdesivir) as a treatment of COVID-19. Veklury, an antiviral drug, is the first treatment approved...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Seyfarth Shaw LLP
    Seyfarth Shaw LLP
  • Article

    New CDC And Wisconsin Guidance Contain Options To Reduce Length Of Quarantine

    The Centers for Disease Control and Prevention (CDC) recently issued revised guidance with options for reducing the length of quarantine for individuals who are asymptomatic...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reinhart, Boerner, Van Deuren SC
    Reinhart, Boerner, Van Deuren SC
  • Article

    Telehealth Update: DEA Issues Long-Awaited Proposed Rule On Prescribing Controlled Substances Via Telehealth

    With just over two months before the COVID-19 Public Health Emergency (PHE) expected expiration on May 11, 2023, the Drug Enforcement Agency (DEA) has finally announced its proposed rule...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Showing 321–340 of 1169 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics